Investors in the Cannabis Market: Page 7

MedMen CEO Adam Bierman Steps Down, Surrenders Super Voting Shares in Company

The news comes amidst a state lawsuit and a series of layoffs at the company in California.

SEC Alleges Pyramid Scheme Run by Fraudulent Cannabis Business Executives in California, Washington

All told, $4.85 million was tied up in Green Acre Pharms, a licensed cannabis business that never generated returns for investors.

Cresco Labs Announces Signing of Senior Secured Credit Agreement

An initial drawdown of up to US$100 million is expected at the end of January, and the agreement includes a mutual option to increase to up to US$200 million.

Aphria Inc. Enters Into Agreement to Receive $100 Million Strategic Investment from Institutional Investor

The funding strengthens Aphria's cash balance pro forma to nearly $600 million.

Curaleaf Secures $300 Million in Capital

Chief Financial Officer Neil Davidson discusses the company’s loan and shares how Curaleaf was able to exceed its initial goal of $275 million.

Village Farms Opts to Receive $5.94 Million Cash Refund from Pure Sunfarms

The refund relates to an additional equity contribution that Village Farms made to Pure Sunfarms on Nov. 19, 2019.

Purpose Investments Inc. Launches Europe’s First Cannabis ETF in Partnership with HANetf

The fund listed Jan. 14 on the Deutsche Boerse XETRA exchange in Germany.

Toronto-Based FSD Pharma Begins Trading on NASDAQ

The stock begins trading under the symbol ‘HUGE’ on Jan. 9, placing FSD Pharma in a select group of 12 Canadian-domiciled cannabis companies trading on the NYSE or NASDAQ.

FSD Pharma to Begin Trading on the NASDAQ Capital Market Under Symbol ‘HUGE’ on Jan. 9, 2020

The company’s shares will continue to be listed on the Canadian Securities Exchange under the symbol ‘HUGE.’

Curaleaf Holdings, Inc. Announces New $275 Million Senior Secured Term Loan Facility

The new financing has no equity component.

Cannabis Conference Pricing Deadline Extended to Jan. 10

Now that we're on the far side of the holiday season, the Cannabis Conference team is extending its Early Bird registration deadline (originally Dec. 27) to Jan. 10.

The Valens Company Announces New Extraction, White Label and Supply Agreements and Updates OTCQX Ticker to 'VLNCF'

The company has announced a four-year extraction and white label agreement with Emerald Health Therapeutics Inc.

Previous Page

Page 7 of 22

Next Page